Ornithine decarboxylase is a transcriptional target of tumor suppressor WT1

Experimental Cell Research

Volumn 247, Issue 1, 1999, Pages 257-266

  Li, Run Sheng ^a   Law, G Lynn ^a   Seifert, Ronald A ^b   Romaniuk, Paul J ^c   Morris, David R ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF VICTORIA   (Canada)

Author keywords

ODC; Ornithine decarboxylase; Polyamines; Transcriptional control; Tumor suppressor; WT1

Indexed keywords

DNA BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GENE PRODUCT; MESSENGER RNA; ORNITHINE DECARBOXYLASE; SYNDECAN; TRANSCRIPTION FACTOR; ZINC FINGER PROTEIN;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CELL STRAIN BHK; CONTROLLED STUDY; GENE EXPRESSION SYSTEM; GENE MUTATION; GENE TARGETING; GENETIC TRANSFECTION; INTRON; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALIA; CRICETINAE;

EID: 0033602039     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4361     Document Type: Article

References (69)

1. Reddy J. C., Licht J. D. The WT1 Wilms' tumor suppressor gene: How much do we really know. BBA Rev. Cancer. 1287:1996;1-28.
2. Rauscher F. J., Morris J. F., Tournay O. E., Cook D. M., Curran T. Binding of the Wilms' tumor locus zinc finger protein to the Egr-1 consensus sequence. Science. 250:1990;1259-1262.
3. Haber D. A., Sohn R. L., Buckler A. J., Pelletier J., Call K. M., Houseman D. E. Alternative splicing and genomic structure of the Wilms' tumor gene WT1. Proc. Natl. Acad. Sci. USA. 88:1991;9618-9622.
4. Bickmore W. A., Oghene K., Little M. H., Seawright A., van Heynihgen V., Hastie N. D. Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript. Science. 257:1992;235-237.
5. Drummond I. A., Rupprecht H. D., Rohwernutter P., Lopezguisa J. M., Madden S. L., Rauscher F. J., Sukhatme V. P. DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1. Mol. Cell Biol. 14:1994;3800-3809.
6. Akasaka Y., Kikuchi H., Hiraoka N., Kato S., Hattori K. A point mutation found in the WT1 gene in a sporadic Wilms' tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome. FEBS Lett. 317:1993;39-43.
7. Baird P. N., Groves N., Haber D. A., Houseman E., Cowell J. K. Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome. Oncogene. 7:1992;2141-2149.
8. Rackley R. R., Flenniken A. M., Kuriyan N. P., Kessler P. P., Stoler M. H., Williams B. G. Expression of the Wilms' tumor suppressor gene WT1 during mouse embryogenesis. Cell Growth Differ. 4:1993;1023-1031.
9. Pelletier J., Schalling M., Buckler A. J., Rogers A., Haber D. A., Housman D. Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes Dev. 5:1991;1345-1356.
10. Pritchard-Jones K., Fleming S., Davison D., Bickmore W., Porteous D., Gosden C., Bard J., Buckler A., Pelletier J., Housman D., van Heynihgen V., Hastie N. The candidate Wilms' tumour gene is involved in genitourinary development. Nature. 346:1990;194-197.
11. Kreidberg J. A., Sariola H., Loring J. M., Maeda M., Pelletier J., Houseman D., Jaenish R. WT-1 is required for early kidney development. Cell. 74:1993;679-691.
12. i. J. Biol. Chem. 270:1995;30760-30764.
13. Haber D. A., Park S., Maheswaran S., Englert C., Re G. G., Hazenmartin D. J., Sens D. A., Garvin A. J. WT1-mediated growth suppression of Wilms' tumor cells expressing a WT1 splicing variant. Science. 262:1993;2057-2059.
14. Huang R. P., Darland T., Okamura D., Mercola D., Adamson E. D. Suppression of v-sis-dependent transformation by the transcription factor, Egr-1. Oncogene. 9:1994;4500-4507.
15. Luo X. N., Reddy J. C., Yeyati P. L., Idris A. H., Hosono S., Haber D. A., Licht J. D., Atweh G. F. The tumor suppressor gene WT1 inhibits ras-mediated transformation. Oncogene. 11:1995;743-750.
16. Englert C., Hou X., Maheswaran S., Bennett P., Ngwu C., Re G. G., Garvin A. J., Rosner M. R., Haber D. A. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J. 14:1995;4662-4675.
17. Menke A. L., Shvarts A., Riteco N., van Ham R. C., van der Eb A. J., Jochemsen A. G. Wilms' tumor 1-KTS isoforms induce p53-independent apoptosis that can be partially rescued by expression of the epidermal growth factor receptor or the insulin receptor. Cancer Res. 57:1997;1353-1363.
18. Hewitt S. M., Hamada S., Mcdonnell T. J., Rauscher F. J., Saunders G. F. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene. Cancer Res. 55:1995;5386-5389.
19. Mccann S., Sullivan J., Guerra J., Arcinas M., Boxer L. M. Repression of the C-myb gene by WT1 protein in T and B cell lines. J. Biol. Chem. 270:1995;23785-23789.
20. Martinerie C., Chevalier G., Rauscher F. J., Perbal B. Regulation of nov by WT1: A potential role for nov in nephrogenesis. Oncogene. 12:1996;1479-1492.
21. Wang Z. Y., Madden S. L., Deuel T. F., Rauscher F. J. The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene. J. Biol. Chem. 267:1992;21999-22002.
22. Drummond I. A., Madden S. L., Rohwer-Nutter P., Bell G. I., Sukhatme V. P., Rauscher F. J. Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science. 257:1992;674-678.
23. Werner H., Roberts C. T., Rauscher F. J., LeRoith D. Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1. Oncogene. 12:1996;621-629.
24. Cook D. M., Hinkes M. T., Bernfield M., Rauscher F. J. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1. Oncogene. 13:1996;1789-1799.
25. Moshier J. A., Skunca M., Wu W., Boppana S. M., Rauscher F. J., Dosescu J. Regulation of ornithine decarboxylase gene expression by the Wilms' tumor suppressor WT1. Nucleic Acids Res. 24:1996;1149-1157.
26. Heby O. Role of polyamines in the control of cell proliferation and differentiation. Differentiation. 19:1981;1-20.
27. Pegg A. E. Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res. 48:1988;759-774.
28. Tabor C. W., Tabor H. Polyamines. Annu. Rev. Biochem. 53:1984;749-790.
29. Morris D. R. A new perspective on ornithine decarboxylase regulation - Prevention of polyamine toxicity is the overriding theme. J. Cell. Biochem. 46:1991;102-105.
30. Law G. L., Morris D. R. Transcriptional control of the ODC gene. Polyamines: Regulation of Molecular Interaction. 1995;Landes, Georgetown. p. 5-26.
31. Luk G. D., Baylin S. D. Ornithine decarboxylase as a biologic marker in familial colonic polyposis. N. Engl. J. Med. 1984;80-83.
32. Holtta E., Sistonen L., Alitalo K. The mechanisms of ornithine decarboxylase deregulation in c-Ha-ras oncogene-transformed NIH 3T3 cells. J. Biol. Chem. 263:1988;4500-4507.
33. Auvinen M., Paasinen A., Andersson L. C., Holtta E. Ornithine decarboxylase activity is critical for cell transformation. Nature. 360:1992;355-358.
34. Singh J., Kelloff G., Reddy B. S. Intermediate biomarkers of colon cancer: Modulation of expression of ras oncogene by chemopreventive agents during azoxymethane induced colon carcinogenesis. Carcinogenesis. 14:1993;699-704.
35. Wrighton C., Busslinger M. Direct transcriptional stimulation of the ornithine decarboxylase gene by fos in PC12 cells but not in fibroblasts. Mol. Cell. Biol. 13:1993;4657-4669.
36. Jaggi R., Friis R., Groner B. Oncogenes modulate cellular gene expression and repress glucocorticoid regulated gene transcription. J. Steroid Biochem. 29:1988;457-463.
37. Pena A., Reddy C. D., Wu S. J., Hickok N. J., Reddy E. P., Yumet G., Soprano D. R., Soprano K. J. Regulation of human ornithine decarboxylase expression by the cMyc-Max protein complex. J. Biol. Chem. 268:1993;27277-27285.
38. Bello-Fernandez C., Packham G., Cleveland J. L. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl. Acad. Sci. USA. 90:1993;7804-7808.
39. Wagner A. J., Meyers C., Laimins L. A., Hay N. c-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ. 4:1993;879-883.
40. Janne J., Alhonen-Hongisto L. Inhibitors of ornithine decarboxylase: Biochemistry and applications. Hayashi S.-I. Ornithine Decarboxylase: Biology, Enzymology and Molecular Genetics. 1989;59-85 Pergamon Press, New York.
41. Berchtold C. M., Kensler T. W., Casero R. A. The polyamine pathway as a target for chemoprevention. Casero R. A. Polyamines: Regulation and Molecular Interaction. 1995;205-231 Landes, Georgetown.
42. Moshier J. A., Dosescu J., Skunca M., Luk G. D. Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression. Cancer Res. 53:1993;2618-2622.
43. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
44. Li R. S., Abrahamsen M. S., Johnson R. R., Morris D. R. Complex interactions at a GC-rich domain regulate cell type-dependent activity of the ornithine decarboxylase promoter. J. Biol. Chem. 269:1994;7941-7949.
45. Abrahamsen M. S., Li R. S., Dietrich-Goetz W., Morris D. R. Multiple DNA elements responsible for transcriptional regulation of the ornithine decarboxylase gene by protein kinase-A. J. Biol. Chem. 267:1992;18866-18873.
46. Tobias K. E., Shor J., Kahana C. C-Myc and Max transregulate the mouse ornithine decarboxylase promoter through interaction with two downstream CACGTG motifs. Oncogene. 11:1995;1721-1727.
47. Bornstein P., Alfi D., Devarayalu S., Framson P., Li P. Characterization of the mouse thrombospondin gene and evaluation of the role of the first intron in human gene expression. J. Biol. Chem. 265:1990;16691-16698.
48. Haber D. A., Timmers H. T., Pelletier J., Call K. M., Houseman D. E. A dominant mutation in the Wilms tumor gene WT1 cooperates with the viral oncogene E1A in transformation of primary kidney cells. Proc. Natl. Acad. Sci. USA. 89:1992;6010-6014.
49. Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA. 89:1992;5547-5551.
50. Turner D. L., Weintraub H. Expression of achaete-scute homolog 3 inXenopus. Genes Dev. 8:1994;1434-1447.
51. Rupp R. A., Snider L., Weintraub H. Xenopus. Genes Dev. 8:1994;1311-1323.
52. Fire A., Harrison S. W., Dixon D. A modular set of lacZ fusion vectors for studying gene expression inCaenorhabditis elegans. Gene. 93:1990;189-198.
53. Roth M. B., Zahler A. M., Stolk J. A. A conserved family of nuclear phosphoproteins localized to sites of polymerase II transcription. J. Cell Biol. 115:1991;587-596.
54. Evan G. I., Lewis G. K., Ramsay G., Bishop J. M. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Biol. Cell. 5:1985;3610-3616.
55. Sanes J. R., Rubenstein J. L. R., Nicoles J. F. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J. 5:1986;3133-3142.
56. Laird P. W., Zijderveld A., Linders K., Rudnicki M. A., Jaenish R., Berns A. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19:1991;4293-4294.
57. McConologue L., Gupta M., Wu L., Coffino P. Molecular cloning and expression of the mouse ornithine decarboxylase gene. Proc. Natl. Acad. Sci. USA. 81:1984;540-544.
58. Dubov K. P., Perry R. P. The gene family encoding the mouse ribosomal protein L32 contains a uniquely expressed intron-containing gene and an unmutated processed gene. Cell. 37:1984;457-468.
59. Hamilton T. B., Barilla K. C., Romaniuk P. J. High affinity binding sites for the Wilms' tumour suppressor protein WT1. Nucleic Acids Res. 23:1995;277-284.
60. Law G. L., Itoh H., Law D. J., Mize G. J., Merchant J. L., Morris D. R. Transcription factor ZBP-89 regulates the activity of the ornithine decarboxylase promoter. J. Biol. Chem. 273:1998;19955-19964.
61. Saffer J. D., Jackson S. P., Annarella M. B. SV40 stimulates expression of the transacting factor Sp1 at the mRNA level. Mol. Cell. Biol. 11:1990;2189-2199.
62. Ayer D. E., Kretzner L., Eisenman R. N. Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell. 72:1993;211-222.
63. Wu S. J., Pena A., Korcz A., Soprano D. R., Soprano K. J. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex. Oncogene. 12:1996;621-629.
64. Maheswaran S., Park S., Bernard A., Morris J. F., Rauscher F. J., Hill D. E., Haber D. A. Physical and functional interaction between WT1 and p53 proteins. Proc. Natl. Acad. Sci. USA. 90:1993;5100-5104.
65. Johnstone R. W., See R. H., Sells S. F., Wang J., Muthukkumar S., Englert C., Haber D. A., Licht J. D., Sugrue S. P., Roberts T., Rangnekar V. M., Shi Y. A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1. Mol. Cell. Biol. 16:1996;6945-6956.
66. Thyberg J., Fredholm B. B. Induction of ornithine decarboxylase activity and putrescine synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor. Exp. Cell Res. 1987;160-169.
67. Pohjanpelto P., Holtta E. Phosphorylation of Okazaki-like DNA fragments in mammalian cells and role of polyamines in the processing of this DNA. EMBO J. 15:1996;1193-1200.
68. Anant S., Axenovich S. A., Madden S. L., Rauscher F. J. Novel replication inhibitory function of the developmental regulator/transcription repressor protein WT1 encoded by the Wilms' tumor gene. Oncogene. 9:1994;3113-3126.
69. Kudoh T., Ishidate T., Moriyama M., Toyoshima K., Akiyama T. G1 phase arrest induced by Wilms tumor protein WT1 is abrogated by cyclin/CDK complexes. Proc. Natl. Acad. Sci. USA. 92:1995;4517-4521.